Refractory status epilepticus describes status epilepticus that continues despite appropriate initial emergency treatment. Super-refractory status epilepticus describes an even more severe situation in which status continues or recurs despite prolonged anaesthetic treatment.
From status epilepticus to refractory status
Status epilepticus becomes refractory when seizure activity continues despite treatment with an initial benzodiazepine and an appropriate second-line antiseizure medicine.
Definitions in practice can vary slightly between protocols, but the central idea is failure of standard early treatment.
What does super-refractory mean?
Super-refractory status epilepticus is usually defined as status epilepticus that continues or recurs 24 hours or more after anaesthetic treatment has begun, including recurrence when anaesthesia is reduced or withdrawn.
It is not a separate epilepsy syndrome. It is a description of treatment resistance during a neurological emergency.
Why prolonged status becomes harder to stop
During prolonged seizure activity, inhibitory and excitatory receptor trafficking and other cellular changes can reduce responsiveness to treatments that work well early in status epilepticus.
This biological evolution is one reason modern emergency practice emphasises rapid recognition and treatment.
Intensive-care treatment
Refractory convulsive status often requires intensive-care support, continuous EEG and intravenous anaesthetic treatment.
Management also includes respiratory and cardiovascular support, temperature and metabolic management, prevention of complications and repeated investigation for the cause.
The cause matters as much as seizure suppression
Stroke, infection, autoimmune encephalitis, toxic or metabolic disorders, acute brain injury and NORSE can all lead to refractory status.
Treating only the electrographic seizures without treating the underlying disease is therefore incomplete care.
Options in super-refractory cases
Specialist teams may consider additional antiseizure medicines, alternative anaesthetic strategies, ketamine, ketogenic dietary therapy and cause-specific immunotherapy, among other approaches.
The evidence for many later-line interventions is observational rather than based on large randomised trials.
Prognosis cannot be reduced to one number
Outcome depends heavily on age, cause, duration, complications, pre-existing health, EEG background and neurological injury.
Super-refractory status is associated with substantial mortality and disability, but meaningful recovery can occur, so prognostication should be cautious and multimodal.
Related reading
Sources and further reading
- Refractory and Super-Refractory Status Epilepticus: Therapeutic Options and Prognosis — 2024
- Status epilepticus: what’s new for the intensivist — 2024
- ILAE definition and classification of status epilepticus
Evidence checked: September 2026.